Alfred E. Buxton

Q: What Schools Are Affiliated With Alfred E. Buxton

Alfred E. Buxton is affiliated with the following schools: University of California, San Francisco

Alfred E. Buxton's AcademicInfluence.com Rankings

Alfred E. Buxton

Medical

#2104

World Rank

#2504

Historical Rank

Cardiology

#183

World Rank

#188

Historical Rank

medical Degrees

Download Badge

Medical

Alfred E. Buxton's Degrees

Doctorate Medicine University of Medicine, Taunggyi

Why Is Alfred E. Buxton Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alfred E. Buxton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006) (2558)
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. (1999) (2480)
Rhythm control versus rate control for atrial fibrillation and heart failure. (2008) (1406)
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association (2022) (935)
[Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. (2006) (485)
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. (2000) (425)
Right ventricular tachycardia: clinical and electrophysiologic characteristics. (1983) (379)
[ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]. (2006) (378)
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. (2007) (373)
Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. (2012) (368)
Risk stratification for sudden cardiac death: current status and challenges for the future† (2014) (336)
Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. (1984) (273)
Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. (1980) (253)
The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures. (1986) (252)
Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. (1983) (251)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel (2006) (244)
Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. (1982) (242)
ACC/AHA/ESC PRACTICE GUIDELINES ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (2006) (238)
Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. (1984) (232)
Ventricular activation during ventricular endocardial pacing. II. Role of pace-mapping to localize origin of ventricular tachycardia. (1982) (224)
Endocardial activation of left bundle branch block. (1984) (222)
Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. (1986) (213)
Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial (2002) (209)
The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia. (1984) (206)
Left ventricular endocardial activation during right ventricular pacing: effect of underlying heart disease. (1986) (204)
Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. (1986) (195)
ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: A report of the ACC/AHA/ACP-ASIM task force on clinical competence (ACC/AHA Committee to develop a clinical competence statement on electrocardiography and ambulatory electrocardiography) endorsed by the (2001) (186)
Electrocardiographic Predictors of Arrhythmic Death and Total Mortality in the Multicenter Unsustained Tachycardia Trial (2004) (184)
Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). (1993) (175)
Endocardial mapping in humans in sinus rhythm with normal left ventricles: activation patterns and characteristics of electrograms. (1984) (172)
Prediction of Long-Term Outcomes by Signal-Averaged Electrocardiography in Patients With Unsustained Ventricular Tachycardia, Coronary Artery Disease, and Left Ventricular Dysfunction (2001) (172)
Identifying patients at risk of sudden death after myocardial infarction: value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction. (1983) (171)
Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease. (1988) (169)
Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. (1997) (163)
ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography. A report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography). (2001) (162)
Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics. (1978) (161)
Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. (1984) (161)
123I-mIBG Scintigraphy to Predict Inducibility of Ventricular Arrhythmias on Cardiac Electrophysiology Testing: A Prospective Multicenter Pilot Study (2008) (157)
The role of P wave duration as a predictor of postoperative atrial arrhythmias. (1981) (157)
ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). (2006) (157)
Risk Stratification for Arrhythmic Sudden Cardiac Death: Identifying the Roadblocks (2011) (156)
Coronary-artery spasm immediately after myocardial revascularization: recognition and management. (1981) (155)
Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. (1985) (143)
Prognostic factors in nonsustained ventricular tachycardia. (1984) (141)
Risk Stratification for Sudden Cardiac Death: A Plan for the Future (2014) (139)
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. (1976) (135)
Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. (1987) (134)
The Response to Procainamide During Electrophysiologic Study for Sustained Ventricular Tachyarrhythmias Predicts the Response to Other Medications (1983) (130)
Hazards of intravenous verapamil for sustained ventricular tachycardia. (1987) (127)
Wearable Cardioverter–Defibrillator after Myocardial Infarction (2018) (119)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (114)
Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease. (1984) (112)
Electrocardiographic changes after cardioversion of ventricular arrhythmias. (1986) (106)
Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies (2016) (105)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (101)
The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. (2009) (99)
Contamination of intravenous infusion fluid: effects of changing administration sets. (1979) (98)
High‐power and short‐duration ablation for pulmonary vein isolation: Safety, efficacy, and long‐term durability (2018) (97)
High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit. (2016) (94)
ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health Records: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (2011) (93)
A swine model of infarct-related reentrant ventricular tachycardia: Electroanatomic, magnetic resonance, and histopathological characterization. (2016) (90)
Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials (2015) (90)
ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). (2006) (89)
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. (2014) (88)
Analysis of the resetting phenomenon in sustained uniform ventricular tachycardia: incidence and relation to termination. (1986) (86)
New Criteria During Right Ventricular Pacing to Determine the Mechanism of Supraventricular Tachycardia (2010) (85)
Electrophysiologic evaluation of syncope in patients with bifascicular block. (1983) (85)
Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia Trial (2004) (85)
Time for a change--a new approach to ICD replacement. (2012) (84)
Entrainment of ventricular tachycardia: explanation for surface electrocardiographic phenomena by analysis of electrograms recorded within the tachycardia circuit. (1988) (82)
QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. (2005) (82)
What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? (1996) (81)
Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction. (1987) (80)
Electrophysiologic studies in nonsustained ventricular tachycardia: relation to underlying heart disease. (1983) (79)
Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea (2017) (79)
Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial (2002) (78)
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. (2014) (77)
Nosocomial Multiply Resistant Klebsiella pneumoniae: Epidemiology of an Outbreak of Apparent Index Case Origin (1979) (77)
Termination of ventricular tachycardia: role of tachycardia cycle length. (1982) (75)
The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. (2007) (75)
Acinetobacter calcoaceticus outbreak associated with peritoneal dialysis. (1978) (74)
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. (2005) (73)
Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. (1987) (73)
Infarct-Related Ventricular Tachycardia: Redefining the Electrophysiological Substrate of the Isthmus During Sinus Rhythm. (2018) (71)
Relation of late potentials to site of origin of ventricular tachycardia associated with coronary heart disease. (1985) (70)
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. (2005) (69)
Risk stratification for sudden death in patients with coronary artery disease. (2009) (69)
Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study. (2016) (68)
B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. (2014) (67)
Effect of &bgr;-Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) (2002) (67)
Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. (1999) (67)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (66)
Programmed ventricular stimulation at a second right ventricular site: an analysis of 100 patients, with special reference to sensitivity, specificity and characteristics of patients with induced ventricular tachycardia. (1983) (65)
Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR (2013) (65)
Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. (2014) (63)
Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival. (1983) (58)
Perioperative coronary arterial spasm: long-term follow-up. (1982) (56)
Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM‐ICD): Rationale and Design of an RCT Currently Underway (2016) (56)
Spontaneous compared with induced onset of sustained ventricular tachycardia. (1988) (55)
Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients. (1983) (54)
Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome (2009) (54)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (53)
Not Everyone With an Ejection Fraction ≤30% Should Receive an ICD (2005) (52)
Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial (2017) (52)
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death (2016) (50)
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. (2007) (50)
Nonsustained Ventricular Tachycardia in Coronary Artery Disease: Relation to Inducible Sustained Ventricular Tachycardia (1996) (49)
Amiodarone: correlation of early and late electrophysiologic studies with outcome. (1986) (48)
Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation. (2014) (48)
Termination of ventricular tachycardia. Evaluation of a new pacing method. (1982) (48)
Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. (2001) (47)
Differences in Electrophysiological Substrate in Patients With Coronary Artery Disease and Cardiac Arrest or Ventricular Tachycardia: Insights From Endocardial Mapping and Signal‐Averaged Electrocardiography (1991) (46)
High-Resolution Mapping of Postinfarction Reentrant Ventricular TachycardiaClinical Perspective (2016) (45)
Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. (2014) (45)
Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias. (1988) (45)
Effect of Baseline Impedance on Ablation Lesion Dimensions: A Multimodality Concept Validation From Physics to Clinical Experience (2018) (44)
ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (2011) (43)
Failure of disposable domes to prevent septicemia acquired from contaminated pressure transducers. (1978) (42)
Eliminating bradyarrhythmias after orthotopic heart transplantation. (1996) (42)
Mechanisms of ventricular tachycardia. (1987) (42)
Left Ventricular Ejection Fraction for Sudden Death Risk Stratification and Guiding Implantable Cardioverter-defibrillators Implantation (2010) (41)
Histopathological Characterization of Radiofrequency Ablation in Ventricular Scar Tissue. (2019) (41)
Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias (2018) (41)
Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. (2015) (40)
Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias. (1984) (39)
Risk stratification for sudden death: do we need anything more than ejection fraction? (2003) (38)
Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: Results of a mmulticenter trial (1996) (37)
Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. (1993) (37)
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association (2023) (36)
Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. (2007) (36)
The Clinical Use of Implantable Cardioverter Defibrillators: Where Are We Now? Where Should We Go? (2003) (36)
The Role of the Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death (2000) (35)
Idiopathic ventricular tachycardia. (1999) (35)
Radiofrequency Ablation of a Supra ventricular Tachycardia Due to Interatrial Conduction From the Recipient to Donor Atria in an Orthotopic Heart Transplant Recipient (1995) (34)
Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. (1985) (33)
Influence of gender on inducibility of ventricular arrhythmias in survivors of cardiac arrest with coronary artery disease. (1991) (33)
Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration. (1989) (33)
Painful left bundle branch block syndrome: Clinical and electrocardiographic features and further directions for evaluation and treatment. (2016) (32)
Entrainment of ventricular tachycardia by atrial depolarizations. (1985) (32)
Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. (1983) (32)
Abnormalities of endocardial activation pattern in patients with previous healed myocardial infarction and ventricular tachycardia. (1986) (32)
Idiopathic Ventricular Fibrillation Originating from the Moderator Band (2013) (31)
Risk Stratification for Sudden Cardiac Death After Myocardial Infarction. (2018) (31)
Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia (2016) (31)
Catheter mapping during sinus rhythm: relation of local electrogram duration to ventricular tachycardia cycle length. (1985) (30)
Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol. (1984) (30)
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials (2017) (30)
Sudden death after myocardial infarction--who needs prophylaxis, and when? (2005) (29)
Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) A Comparison of Whites Versus Blacks (2003) (29)
Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy (2013) (28)
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. (2001) (28)
Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy. (2016) (28)
Identifying the High Risk Patient with Coronary Artery Disease—Is Ejection Fraction All You Need? (2005) (28)
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. (2011) (28)
The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. (2011) (27)
Genome‐Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study) (2018) (27)
Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm. (1988) (26)
Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. (1984) (26)
Ablation of Reentry-Vulnerable Zones Determined by Left Ventricular Activation From Multiple Directions: A Novel Approach for Ventricular Tachycardia Ablation (2020) (25)
Prevention of ventricular tachycardia induction during right ventricular programmed stimulation by high current strength pacing at the site of origin. (1987) (25)
Discordant results of programmed ventricular stimulation at different right ventricular sites in patients with and without spontaneous sustained ventricular tachycardia: a prospective study of 56 patients. (1984) (24)
Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors. (2015) (24)
Prognosis following sustained ventricular tachycardia occurring early after myocardial infarction. (1988) (24)
Coexistent Types of Atrioventricular Nodal Re-Entrant Tachycardia (2015) (23)
Relation of mode of induction and cycle length of ventricular tachycardia: analysis of 104 patients. (1983) (23)
Radiofrequency ablation of a supraventricular tachycardia due to interatrial conduction from the recipient to donor atria in an orthotopic heart transplant recipient. (1995) (23)
Prognostic Significance of Nonsustained Ventricular Tachycardia Identified Postoperatively After Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction (2002) (22)
Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes (2018) (22)
Percutaneous stellate ganglia block for acute control of refractory ventricular tachycardia. (2012) (22)
Implantable Cardioverter–Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium (2015) (21)
Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. (2014) (21)
Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities). (2018) (21)
Ischemia-induced changes in human endocardial electrograms during percutaneous transluminal coronary angioplasty. (1994) (20)
The human atrial strength-interval relation. Influence of cycle length and procainamide. (1989) (20)
Predicting appropriate shocks in patients with heart failure: Patient level meta‐analysis from SCD‐HeFT and MADIT II (2016) (20)
The Effects of Isoproterenol on the Cardiac Conduction System (1997) (19)
Temperature-Controlled Radiofrequency Ablation Using Irrigated Catheters: Maximizing Ventricular Lesion Dimensions While Reducing Steam-Pop Formation. (2020) (19)
Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. (1986) (19)
Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. (2014) (19)
Electrophysiologic effects of intravenous metoprolol. (1984) (19)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. (2020) (17)
Isolated dextroversion of the heart with asymmetric septal hypertrophy. (1976) (17)
Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate. (2019) (17)
Risk stratification for sudden cardiac death in North America - current perspectives. (2016) (17)
Mode of Induction of Ventricular Tachycardia and Prognosis in Patients with Coronary Disease: The Multicenter UnSustained Tachycardia Trial (MUSTT) (2008) (17)
Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. (1996) (17)
Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia. (1993) (17)
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. (2013) (16)
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs. (1986) (16)
Influence of the site of stimulation on the resetting phenomenon in ventricular tachycardia. (1986) (16)
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. (2007) (16)
Cycle length-dependent effects on normal and abnormal intraventricular electrograms: effect of procainamide. (1988) (16)
Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement (2018) (15)
Electrophysiologic sequelae of chronic myocardial infarction: local refractoriness and electrographic characteristics of the left ventricle. (1986) (15)
Safety of nerve conduction studies in patients with peripheral intravenous lines (2010) (15)
Sudden cardiac death risk stratification in patients with heart failure. (2011) (15)
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). (2007) (15)
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015 (2018) (13)
Nonsustained ventricular tachycardia. (2000) (13)
Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter. (2016) (13)
Implantable cardiac pacemakers and defibrillators : all you wanted to know (2006) (13)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (13)
Catheter ablation of atrioventricular bypass tracts. Still an investigational procedure. (1989) (13)
Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratification of patients for primary prevention implantable cardioverter-defibrillator implantation. (2013) (12)
The Clinical Significance of Nonsustained Ventricular Tachycardia (1993) (12)
The Multicenter UnSustained Tachycardia Trial (MUSTT) (1999) (12)
Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators. (2019) (12)
Sudden death in ischemic heart disease - 2017. (2017) (12)
Timing of the right ventricular apical electrogram during sustained ventricular tachycardia: relation to surface QRS morphology and potential clinical implications. (1984) (12)
Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation (2019) (12)
True Bipolar Defibrillator Leads Have Increased Sensing Latency and Threshold Compared with the Integrated Bipolar Configuration (2007) (11)
Programmed ventricular stimulation: not dead. (2014) (11)
Coronary Sinus and Fossa Ovalis Ablation: Effect on Interatrial Conduction and Atrial Fibrillation (2007) (11)
Treatment of painful left bundle branch block syndrome with cardiac resynchronization therapy or right-ventricular pacing (2019) (11)
Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. (1991) (11)
ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. (2011) (11)
Primary Prevention of Sudden Cardiac Death: Trials in Patients with Coronary Artery Disease (2003) (11)
Tachyarrhythmias associated with programmable automatic atrial antitachycardia pacemakers. (1983) (11)
American College of Cardiology report on ECGEXAM. (1997) (11)
Sudden Cardiac Death Prediction and Prevention (2010) (10)
Spatial characterization of the tachycardia circuit of atrioventricular nodal re-entrant tachycardia. (2021) (10)
Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned? (2017) (10)
Prognosis in patients with intra-Hisian conduction disturbances. (1984) (9)
Implantable cardioverter-defibrillators should be used routinely in the elderly. (2006) (9)
889-6 A simple model using the MUSTT database can stratify total mortality and sudden death risk of coronary disease patients (2004) (9)
Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. (2010) (9)
Current approaches to evaluation and management of patients with ventricular arrhythmias. (2001) (9)
Optimal Timing of Implantable Cardioverter‐Defibrillator Implantation After Myocardial Infarction: A Decision Analysis (2010) (8)
Noninvasive electrophysiology in risk assessment and screening. (2018) (8)
Practical Clinical Electrophysiology (2017) (8)
Implantable Cardiac Pacemakers and Defibrillators (2006) (8)
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. (2012) (8)
Horizontal and Longitudinal Dissociation of the A‐V Node During Atrial Tachycardia (1983) (7)
Global Electrical Heterogeneity Associated with Drug-Induced Torsades de Pointes. (2020) (7)
Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit. (2012) (7)
Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. (1990) (7)
Electrophysiologic effects of intravenous timolol. (1983) (7)
Sinus Mapping in Patients with Cardiac Arrest and Coronary Disease—Results and Correlation with Outcome (1989) (7)
The Clinical Spectrum of Ventricular Tachyarrhythmias in Patients with Coronary Artery Disease (1995) (6)
Nonpharmacologic therapy of ventricular tachycardia. (1988) (6)
Activation During Sinus Rhythm in Ventricles With Healed Infarction: Differentiation Between Arrhythmogenic and Nonarrhythmogenic Scar. (2019) (6)
Application of the signal-averaged electrocardiogram in patients with nonsustained ventricular tachycardia after myocardial infarction: implications for prediction of sudden cardiac death risk. (1988) (6)
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? (2014) (6)
Medical versus surgical treatment of tachydysrhythmias. (1984) (5)
Heat-stable enterotoxigenic Escherichia coli and necrotizing enterocolitis: lack of an association. (1977) (5)
Sudden cardiac death won't go away: what are we to do? (2011) (5)
Electrophysiology Studies in Patients Undergoing ICD Implantation: Findings from the NCDR® (2012) (5)
Effect of high-current stimulation in patients with sustained ventricular tachycardia rendered noninducible by antiarrhythmic drugs. (1992) (5)
Human endocardial activation: Abnormalities resulting from coronary artery disease (1982) (4)
Work-up and management of patients with sustained and nonsustained monomorphic ventricular tachycardias. (1993) (4)
SURVIVAL BENEFIT OF THE PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS: DOES AGE MATTER? A PATIENT-LEVEL META-ANALYSIS OF 5 CLINICAL TRIALS (2014) (4)
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial. (2001) (4)
Primary ablation of atrial flutter and atrial fibrillation. (1996) (4)
Conquest of Ventricular Tachycardia: Insights Into Mechanisms, Innovations in Management: Contribution of Mark E. Josephson, MD, to Clinical Electrophysiology. (2017) (4)
Influence of Renal Function on Mortality and Ventricular Arrhythmias in Patients Undergoing First Implantable Cardioverter‐Defibrillator Generator Replacement (2015) (4)
Atrial conduction: Effects of extrastimuli in patients with and without atrial dysrhythmias (1982) (4)
Macroscopic T-wave alternans in a patient with takotsubo cardiomyopathy and QT prolongation. (2014) (3)
Positive Psychotherapy Improves Cardiac Electrical Stability and Mood in ICD Patients: PAM-ICD Trial Results. (2021) (3)
SCAR HETEROGENEITY ON CARDIAC MAGNETIC RESONANCE IMAGING IS A PREDICTOR OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY: 10 YEARS OF EXPERIENCE (2012) (3)
N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention ICDs. (2020) (3)
Implantable Cardioverter – Defibrillator Use in Older Adults (3)
Implantable loop recorder in survivors of acute myocardial infarction: a glimpse of reality? (2010) (3)
Association between the Charlson comorbidity index and outcomes after implantable cardioverter defibrillator generator replacement (2019) (3)
Results of Electrophysiological Testing and Long‐Term Follow‐Up in Patients Sustaining Cardiac Arrest Only While Receiving Type IA Antiarrhythmic Agents (1992) (2)
Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt. (2019) (2)
Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines. (2015) (2)
1116-39 QRS duration does not predict occurrence of ventricular tachyarrhythmias in primary prevention patients with implantable cardioverter-defibrillators (2004) (2)
Bradyarrhythmias and AV Block (2020) (2)
ArrhythmiasAbstractsElectrocardiographic predictors of arrhythmic death and total mortality in the Multicenter Unsustained Tachycardia Trial (2004) (2)
Abstract 13142: Implantable Cardioverter Defibrillators Continue to Offer Mortality Benefit After Improvement in Ejection Fraction to Above 35%: Results From the Sudden Cardiac Death in Heart Failure Trial (2016) (2)
Electrophysiologic testing of survivors of cardiac arrest. (1985) (1)
Abstract 2934: Prolonged QRS Duration is Associated with a Marked Increase in Mortality in the AF-CHF Study (2008) (1)
A Guide to the Clinical Significance and Management (2001) (1)
The natural history of perioperative coronary spasm (1982) (1)
Introduction to Cardiac Electrophysiology , the Electrocardiogram , and Cardiac Arrhythmias (2001) (1)
Multicenter UnSustained Tachycardia Trail (2000) (1)
Surgical therapy of ventricular tachycardia (1987) (1)
“Popping” during radiofrequency catheter ablation: an in vitro model — new observations (1998) (1)
Abstract 12990: Genome-wide Associations of Global Electrical Heterogeneity ECG Phenotype: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies (2016) (1)
Abstract 20649: Optimal Medical Therapy Use Among Implantable Cardioverter-Defibrillator Recipients: Insights from the NCDR ICD Registry (2010) (1)
Thirty years of catheter ablation for ventricular tachycardia. (2021) (1)
Nonsustained Ventricular Tachycardia Update: Epidemiology, Pathophysiology, Immediate Evaluation and Management, Long-Term Management, Experimental and Theoretical Developments (1997) (1)
Nonsustained ventricular tachycardia. A guide to the clinical significance and management. (2001) (1)
Feasibility of real time integration of high-resolution scar images with invasive electrograms in electro-anatomical mapping system in patients undergoing ventricular tachycardia ablation (2013) (1)
The use of multiple extrastimuli during programmed ventricular stimulation: how many should be used? (1985) (1)
The role of electrophysiological studies in the management and therapy of recurrent ventricular tachycardias in patients with ischemic heart disease (1987) (1)
Abstract 2450: New Criteria During Ventricular Overdrive Pacing to Differentiate ORT From AVNRT (2009) (1)
THE EFFECT OF DIGOXIN USE ON OUTCOMES IN PATIENTS WITH DURABLE LVADS: AN INTERMACS ANALYSIS (2020) (1)
Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop Sudden Cardiac Death Prediction and Prevention: Report From a National (2010) (1)
Consultation length: general practitioners' attitudes and practices. (1985) (1)
Abstract 12224: Electrocardiographic Beat-to-Beat QT Interval is affected by Phases of Respiration: The Atherosclerosis Risk in Communities Study (2016) (1)
Hemodynamic intolerance and pericardial effusion associated with high-frequency jet ventilation during pulmonary vein isolation (2021) (1)
A Glimpse of Reality? (2010) (1)
T1 MAPPING AND QUANTIFICATION OF DIFFUSE MYOCARDIAL FIBROSIS IN PATIENTS WITH VENTRICULAR TACHYCARDIA (2015) (1)
1014-210 Coronary sinus Os and fossa ovalis ablation: Effect on interatrial conduction and inducibility of atrial fibrillation (2004) (1)
Abstract 13090: Increased U Vector Magnitude is Associated With Increased Risk of Sudden Cardiac Death - The Atherosclerosis Risk in Communities Study (2016) (0)
LEFT BUNDLE BRANCH BLOCK Endocardial activation of left bundle branch block (2005) (0)
Wide Complex Tachycardia in a Young Woman (2021) (0)
Abstract MP081: Short-long-short Sequence of RR Intervals is Associated With Increased Risk of Sudden Cardiac Death: the Atherosclerosis Risk in Community Study (2017) (0)
Conversion, Compromise, and Conversation-Moving to a Sensible Middle When Addressing Implantable Cardioverter-Defibrillator Therapy-Reply. (2019) (0)
Sudden cardiac death--a perspective. (1984) (0)
Time to termination of post-infarct ventricular tachycardia by radiofrequency catheter ablation suggests superficial endocardial reentry (1998) (0)
Rightventricular tachycardia: clinical and electrophysiolog ic characteristics (1983) (0)
Chapter 98 – Results of Clinical Trials of Automatic External Defibrillators and Implantable Cardioverter-Defibrillators in Patients at Risk for Sudden Death (2004) (0)
Acute management of atrial fibrillation. (2004) (0)
Indications for the Implanted Cardioverter‐Defibrillator (2007) (0)
Should elderly patients get ICDs (2006) (0)
Abstract 12465: Association of Markers of Electrical Heterogeneity With Premature Ventricular Contractions on 12-Lead Electrocardiogram (2016) (0)
A new ECG section in HeartRhythm by Josephson and Wellens (2014) (0)
Risk Stratification forSsudden Death in Patients with Coronary Artery Disease (2008) (0)
Response to the Editor: (2007) (0)
P2-75: Events: Designation & distribution in the Multicenter UnSustained Tachycardia Trial (MUSTT) (2006) (0)
Pharmacologic therapy for survivors of sudden death based on programmed stimulation. (1985) (0)
THERAPY OF VENTRICULAR TACHYCARDIA : ROLE OF ELECTROPHYSIOLOGY STUDIES 1987 (1987) (0)
Abstract 15908: Association Between Global Electrical Heterogeneity and Cardiac Structure and Function in the General Population - The Atherosclerosis Risk in Communities Study (2016) (0)
Abstract 16542: Hypotension and Pericardial Effusion Associated With High Frequency Jet Ventilation (2020) (0)
AB7-4: Biventricular pacing allows maintenance of sinus rhythm in patients with persistent atrial fibrillation (2006) (0)
Abstract 12188: Utilization Rates of Primary Prevention Implantable Cardioverter-Defibrillators: A 2012 Calculation for a Midwestern Health Referral Region (2013) (0)
VENTRICULAR 1 Endocardial catheter mapping in patients in sinus rhythm : relationship to underlying heart disease and ventricular arrhythmigs (2005) (0)
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not Everyone With an Ejection Fraction < 30% Should Receive an Implantable Cardioverter-Defibrillator C ONTROVERSIES IN C ARDIOVASCULAR M EDICINE (2005) (0)
INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE EFFICACY OF PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: A META-ANALYSIS OF THREE RANDOMIZED TRIALS (2013) (0)
Management of the non-inducible patient. (2002) (0)
Failure of Disposable Domes (1980) (0)
Atrial fibrillation and flutter: overview. (2004) (0)
Programmed Stimulation of the Ventricles - Back to the Future (1997) (0)
Direct current cardioversion for atrial fibrillation and flutter. (2004) (0)
Abstract 16058: Association Between Global Electrical Heterogeneity and Left Ventricular Mechanical Dyssynchrony in the General Population - The Atherosclerosis Risk in Communities Study (2016) (0)
Use of programmed electrical stimulation to predict sudden death after myocardial infarction. (1985) (0)
Dose-dependent differential effects of isoproterenol on sinus and atrioventricular nodes (1996) (0)
Abstract 16972: Premature Ventricular Complex Characteristics Are Associated With Sudden Cardiac Death: the Atherosclerosis Risk in Communities (ARIC) Study and the Cardiovascular Health Study (CHS) (2016) (0)
Classification and treatment of non-sustained ventricular tachycardia (2018) (0)
Identification of suitable patients for ICD therapy. (2018) (0)
Mechanism of lethal arrhythmias: results of programmed electrical stimulation. (1985) (0)
Substrates of atrial fibrillation in patients with preexcitation (1984) (0)
Abstract 18679: A Novel Volumetric Index of Left Ventricular Sphericity Independently Predicts Appropriate ICD Therapy (2014) (0)
Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply. (2017) (0)
Can acute drug testing with programmed stimulation predict potential proarrhythmic effects (1991) (0)
Subendocardial Temperature Differences During Radiofrequency Catheter Ablation: Normal vs Scar Tissue (1998) (0)
For-profit health plans. (1996) (0)
Cardiac Mapping in Ventricular Tachycardia (2017) (0)
Narrow QRS Complex Ventricular Tachycardia (2020) (0)
Clinical Predictors of Antiarrhythmic Drug Response in the MUSTT Trial (1998) (0)
Abstract 12202: New York Heart Association Class and the Mortality Benefit From Primary Prevention Implantable Cardioverter Defibrillator Use: A Pooled Analysis of 4 Randomized Control Trials (2016) (0)
Abstract 11047: The Use of Electrophysiology Studies in the Post-AVID and Post-SCD-HeFT Era: Data from the NCDR® ICD Registry™ (2010) (0)
Abstract 12101: Vectorcardiographic QRS and T Loop Roundness is Associated With Sudden Cardiac Death: The Atherosclerosis Risk in Communities and the Cardiovascular Health Study (2016) (0)
Entrainment ofventricular tachycardia: explanation forsurface electrocardiogra phic phenomena byanalysis ofelectrograms recorded within thetachycardia circuit (1988) (0)
Abstract 1664: Impact of Ischemic Burden and Revascularization on Outcomes among Patients Receiving Drug Therapy Versus an Implantable Cardioverter Defibrillator in MUSTT: Evidence for Ischemia Induced Proarrhythmia (2007) (0)
Nonsustained Ventricular Tachycardia Update: Epidemiology, Pathophysiology, Immediate Evaluation & Management, Long-term Management, Experimental (2001) (0)
Abstract 13695: Global Electrical Heterogeneity Risk Score Predicts Sudden Cardiac Death in the General Population (2015) (0)
Macroscopic T-wave Alternans in a Patient with Takotsubo's Cardiomyopathy (2014) (0)
Abstract 30: Global Electrical Heterogeneity on Electrocardiogram is Associated with Sudden Cardiac Death After Adjustment for Ejection Fraction (2016) (0)
The signal averaged ECG in patients with nonsustained ventricular tachycardia — a perspective (1993) (0)
PO-640-05 GLOBAL ELECTRICAL HETEROGENEITY AND CARDIAC MEMORY CHANGES DISTINGUISH ACUTE FROM CHRONIC LEFT BUNDLE BRANCH BLOCK (2022) (0)
705-6 Post-Infarct Ventricular Tachycardia: Success Rate of Catheter Ablation (1995) (0)
Riskstratificationforsuddencardiacdeath:current status and challenges for the future † (2014) (0)
ASSOCIATION BETWEEN SPATIAL VENTRICULAR GRADIENT DIRECTION AND REGIONAL MYOCARDIAL DEFORMATION IN THE GENERAL POPULATION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alfred E. Buxton?

Alfred E. Buxton is affiliated with the following schools:

University of California, San Francisco